2019 Cannabis Business Award's Publication of the Year |
WEDNESDAY, SEPTEMBER 20, 2023 |
FMCPG HAS BEEN SERVING THE PHYSICAN COMMUNITY
SINCE 2020 |
REGISTER FOR TONIGHT'S MEETING WEDNESDAY, SEPTEMBER 20, 2023 AT 6:30PM THE "FLORIDA MEDICAL CANNABIS PHYSICIAN GROUP" (FMCPG)
FOR ALL "MEDICAL MARIJUANA DOCTORS" AND "MMTC DIRECTORS ONLY " TOPICS TO BE DISCUSSED THIS YEAR LEGISLATIVE PRIORITIES FOR TALLAHASSEE
UPDATES ON RFE REQUESTS
REPORTING OF BAD PLAYERS PROTECTING YOUR MEDICAL CANNABIS PRACTICE Becoming a Chapter of the Society of Cannabis Clinicians
QUESTIONS FROM PHYSICIANS HOW TO BEST ANSWER YOUR PATIENT QUESTIONS |
MEDICAL CANNABIS PHYSICIAN
PROMOTION PACKAGE BY CANNABIS NEWS FLORIDA ARTICLE: Physician will contribute an article of 350 words**. This article will appear in the Cannabis News Florida e-newsletter for one month (4 weeks).
E-MAIL BLAST: Cannabis News Florida will send out one e-mail blast promoting the Physician to the other physicians in three zip code areas or one city to be determined by the Physician. The Physician will supply the information for the email blast. The Article above can be used in the e-mail blast.
The cost of this program is ONLY $500.
**Cannabis News Florida will assign a writer for a telephone interview with the Physician and create the article to be published. Physician shall have the right to review and approve the article before publication for an additional cost of $100.
IF YOU ARE INTERESTED, PLEASE EMAIL ME AT CHARLES@CANNABISNEWSFLORIDA.COM OR CALL MY CELL AT 954-605-4785 |
NEWS FROM THE PAST WEEK
RELATING TO THE BUSINESS OF MMTC'S IN FLORIDA Click on Company Logo to be Transferred to Web Site |
TRULIEVE OPENING MEDICAL CANNABIS DISPENSARY IN PACE, FLORIDA
Company celebrates grand opening and expands medical cannabis access to patients in Escambia and Santa Rosa counties
TALLAHASSEE, Fla., September14, 2023 — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the United States, today announced the opening of a new medical dispensary located at 5037 Hwy 90, Pace, Fla. The new location will be open 9 a.m. – 8:30 p.m. Monday through Saturday and 11 a.m. – 8 p.m. on Sundays.
The Pace dispensary offers greater access to Florida medical cannabis patients in Santa Rosa and Escambia counties across the Interstate 10 corridor and resides in its own freestanding building with dedicated parking for customers and a comfortable, modern reception area for patients.
“We consistently seek opportunities to better serve medical cannabis patients with convenient locations, great customer service experiences and a broad selection of top-quality products,” said Trulieve’s Chief Executive Officer Kim Rivers. “Trulieve is thrilled to bring a new dispensary to the Pace community.”
READ MORE |
COLUMBIA CARE UNVEILS NEW NAME AND BRAND IDENTITY – THE CANNABIST COMPANY – TO BRING PASSION AND PEOPLE TO THE FOREFRONT
Company to Begin Trading Under CBST on Cboe Canada as of September 21
NEW YORK—September 19, 2023– Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., announced today its change in legal name to The Cannabist Company Holdings Inc. and will rebrand to The Cannabist Company (“Company”). The rebranding reflects the Company’s continued dedication to building a cannabis company for the future, which fosters innovation, creativity, and passion across its teams, adult-use and medical customers, partners, and the industry. In addition to the rebrand, the Company’s common shares and warrants will trade under the symbols “CBST” and “CBST.WT”, respectively, on Cboe Canada effective Thursday, September 21, 2023.
READ MORE |
COLUMBIA CARE ANNOUNCES PRIVATE PLACEMENT OF US$25 MILLION AND EXECUTES ON NEXT PHASE OF BALANCE SHEET IMPROVEMENT INITIATIVES
September 18, 2023– Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today announced that it has entered into subscription agreements with institutional investors (the “Investors”), for the purchase and sale of 22,244,210 units of the Company (the “Units”) at a price of C$1.52 per Unit (the “Issue Price”) pursuant to a private placement (the “Offering”), for aggregate gross proceeds of approximately C$33.8 million or approximately US$25 million (the “Initial Tranche”).
The Investors will have the option to purchase US$25 million in additional Units at a price equal to the Issue Price, upon written notice to the Company at any time up to 45 days following the date hereof (the “Investor Option”). In connection with the transaction, the Company and the investors entered into a customary registration rights agreement. The Units will be subject to limited lock-up requirements.
READ MORE |
NEW NAME HOUSE OF PLATINUM CANNABIS |
VERANO LAUNCHES ROUND UP FOR CANNABIS REFORM DISPENSARY DONATION PROGRAM BENEFITTING THE WELDON PROJECT’S MISSION GREEN
Company builds on groundbreaking 2022 partnership that raised $140,715 supporting Mission Green , spawned the formation of the Mission Green Alliance, and contributed to the release of Luke Scarmazzo
Verano’s Round Up for Cannabis Reform program offers adult use customers and medical patients the option to round up purchases to the nearest dollar to donate directly to Mission Green
Fundraising effort encompasses 127 of the Company’s signature Zen Leaf™ and MÜV™ dispensaries in 12 states1
Verano’s active operations span 13 states, comprised of 132 dispensaries and 14 cultivation and processing facilities with more than 1 million square feet of cultivation capacity
CHICAGO, September 18, 2023 — Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the launch of the Company’s Round Up for Cannabis Reform dispensary donation program benefitting The Weldon Project’s Mission Green and the non-profit organization’s advocacy for cannabis-related criminal justice reform. Round Up for Cannabis Reform allows guests at 127 of Verano’s signature Zen Leaf and MÜV dispensaries across 12 states to round up purchases to the nearest dollar to directly support Mission Green’s cannabis clemency, advocacy, and criminal justice reform initiatives.
READ MORE |
PLANET 13 ANNOUNCES COMPLETION OF CHANGE IN DOMICILE TO NEVADA AND OTC MARKET AND TRADING SYMBOL CHANGE
September 15, 2023 – Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNHF) (“Planet 13” or the “Company“), a leading vertically-integrated multi-state cannabis company, today announced the completion of its previously announced plan of arrangement pursuant to which the Company was continued from the jurisdiction of the Business Corporations Act (British Columbia) and domesticated under the Nevada Revised Statutes to the State of Nevada (the “Nevada Domestication“).
The Nevada Domestication was overwhelmingly approved by shareholders at Planet 13’s Annual General and Special Meeting of Shareholders held on Thursday, July 27, 2023. The British Columbia Supreme Court issued its Final Order on August 3, 2023. The Company completed the Nevada Domestication on September 15, 2023 after market close when the necessary filings were made with, and made effective by, the Secretary of State of the State of Nevada.
READ MORE |
NATIONAL AND INTERNATIONAL NEWS |
MARIMED’S BUBBY’S BAKED INTRODUCES NEW THC-INFUSED BLUEBERRY MUFFIN BITES TO START THE DAY ON A HIGH NOTE
September 13, 2023 — Leading multi-state cannabis operator MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD) headed to the blueberry bush to create the latest addition to its Bubby’s Baked™ THC-infused soft baked goods line of edibles. The Company’s new Blueberry Muffin bites are soft and baked in small batches, a made-from-scratch ode to breakfast. They join the popular Bubby’s Baked line inspired by the original pot brownie recipe and are available at select dispensaries in Massachusetts, Maryland, and Delaware.
Each Bubby’s Baked Blueberry Muffin bite is an enticing combination of sweetness and tartness, bursting with real blueberries and infused with full-spectrum cannabis. With 35% of cannabis consumers saying they have recently enjoyed a cannabis baked good, Bubby’s Baked Blueberry Muffin bites are sure to satisfy the most discerning sweet tooth. In Massachusetts, they are precision-dosed with 5 mg of cannabis; in Maryland and Delaware, they are available with 10 mg of cannabis.
READ MORE |
NEW REPORT REVEALS PRE-ROLLS EMERGE AS THE SECOND-LARGEST PRODUCT CATEGORY IN CANADA, POISED TO OVERTAKE FLOWER AS THE LEADING CATEGORY
Infused pre-rolls take center stage in the Canadian cannabis market, with a staggering growth rate of nearly 606% over the past year
Data shows pre-rolls are poised to overtake flower as the leading product category in Canada
KENT, Wash., September 18, 2023 — Custom Cones USA, the cannabis industry experts in pre-rolls, pre-roll packaging, and pre-roll manufacturing solutions, today released a report revealing that pre-rolls emerged as the second-largest product category in Canada, poised to overtake flower as the leading category. Notably, infused pre-rolls have seized the spotlight with a staggering growth rate of nearly 606% over the past year. Specifically, infused pre-rolls grew from 6.2% of total sales in January 2022 to an incredible 29.8% of total sales by February 2023, a growth rate of nearly 606%.
In 2022, Canada Experienced a 54% Increase in Pre-Roll Sales Revenue
The Canadian pre-roll segment continues to experience robust growth, with total pre-roll revenues exceeding CAD$1 billion in 2022, reflecting a staggering increase of more than 54%. This remarkable surge in sales was observed across every tracked province, from Saskatchewan and Alberta, which saw growth rates of 33% and 37%, respectively, to British Columbia, with nearly 54% growth, and a remarkable 69% increase in Ontario, the country’s most populous province. One major growth driver is the increase in sales of the pre-rolls, particularly infused pre-rolls.
READ MORE |
ARTELO BIOSCIENCES TO PRESENT AT THE 13TH CONGRESS OF THE EUROPEAN PAIN FEDERATION ON SEPTEMBER 20TH
September 13, 2023 — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions, today announced that Professor Saoirse O’Sullivan, Artelo’s Vice President of Translational Sciences, will be presenting at the 13th Congress of the European Pain Federation (EFIC) being held September 20-22, 2023 at the HUNGEXPO Exhibition Centre in Budapest, Hungary.
Professor O’Sullivan’s presentation, titled, “Effects of the FABP5 Inhibitor, ART26.12, in Oxaliplatin-Induced Peripheral Neuropathy in Rats,” is scheduled for 6:30 a.m. ET / 12:30 p.m. CEST on Wednesday, September 20, 2023.
READ MORE |
URBAN-GRO, INC. SIGNS MULTIPLE CONTRACTS WITH CLIENTS IN THE CANNABIS SECTOR FOR AN AGGREGATE VALUE OF MORE THAN $3 MILLION
September 13, 2023 — urban-gro, Inc. (Nasdaq: UGRO) (“urban-gro” or the “Company”), an integrated professional services consulting firm, today announced that the Company signed more than $3 million of contracts spread across four clients in the cannabis sector. Collectively, the contracts include architecture and design, engineering, and equipment integration services for clients in the Northeastern United States, Midwestern United States, and Western Europe. The Company anticipates that the revenue for these projects will be predominantly recognized over the next three quarters.
READ MORE |
URBAN-GRO, INC. SIGNS MULTIPLE CONTRACTS WITH CLIENTS IN THE INDUSTRIAL, AEROSPACE, LABORATORIES, AND HOSPITALITY SECTORS FOR AN AGGREGATE VALUE OF MORE THAN $2 MILLION
September 14, 2023 — urban-gro, Inc. https://www.urban-gro.com/ (Nasdaq: UGRO) (“urban-gro” or the “Company”), an integrated professional services consulting firm, today announced that the Company signed more than $2 million of contracts spread across existing clients in target sectors including industrial, aerospace, laboratories, and hospitality. Collectively, the contracts include architecture and design, engineering, and construction management services for clients in the Midwest and Southern United States. The Company anticipates that the revenue for these projects will be predominantly recognized over the next two quarters. Additionally, and not contemplated in the aforementioned contract value, urban-gro signed a master service agreement (MSA) to provide engineering services (Mechanical, Electrical, Plumbing, and Fire Protection) for two national hotel chains in the United States.
READ MORE |
OPTIMI HEALTH CELEBRATES ENCOURAGING RESULTS FROM THE MAPS PHASE 3 MDMA-ASSISTED THERAPY CLINICAL TRIAL
September 14, 2023 — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian psychedelics drug research and formulation company, is pleased to see the positive and encouraging outcomes from the MAPS Phase 3 MDMA-Assisted Therapy (MDMA-AT) Clinical Trial published today on Nature Medicine. The Company considers the results to be a substantial step forward in the treatment of individuals grappling with moderate to severe Post-Traumatic Stress Disorder (PTSD). The study, conducted across multiple sites, showcases the potential of MDMA-AT to significantly reduce PTSD symptoms and functional impairment, indicating it as a promising therapeutic avenue.
The randomized, double-blind, confirmatory Phase 3 study focused on the assessment of the efficacy and safety of MDMA-assisted therapy in comparison to placebo with identical therapy. This groundbreaking trial was notably diverse, including a significant representation from the Hispanic/Latino community (26.9%) and individuals identifying as other than White (33.7%), presenting a comprehensive insight into the therapy’s effectiveness across a broad spectrum of individuals.
READ MORE |
LIFEIST STRENGTHENS BOARD WITH NEW APPOINTMENT AND ANNOUNCES CHANGES TO CHIEF FINANCIAL OFFICER AND AUDITOR
September 14, 2023 — Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough companies that transform human wellness, is pleased to announce that John C. Sinclair has joined the Company’s board of directors and has been appointed as Chief Financial Officer (“CFO”), on an interim basis, until a suitable replacement is found. Mr. Sinclair replaces Slava Klems, the former CFO, who is leaving her current role with Lifeist to pursue new opportunities. The Company is actively reviewing potential candidates for the role. As a member of the board, Mr. Sinclair will also serve as the chairperson of the Audit Committee.
“I am extremely pleased to welcome John to the board of directors and as our interim CFO,” said Meni Morim, CEO of Lifeist Wellness. “John is an accomplished leader with an impressive track record of driving financial strategies across many sectors. He has experience leading new business development, strategic planning and oversight of all financial matters. John is very familiar with Lifeist, as he was the Company’s audit partner for several years, giving him a unique vantage point. I am confident that his background and strong financial acumen makes him a valuable addition to the board to continue Lifeist’s growth trajectory and achieve our financial goals.”
READ MORE |
BELOW ARE THE LINKS TO THE DIRECTORY OF FLORIDA CANNABIS DOCTORS AND
DISPENSARIES IN THE STATE OF FLORIDA |
QUALIFIED PATIENTS OVER 845,000 AND 590 DISPENSING LOCATIONS
|
LATEST OMMU REPORTS FROM OFFICE OF MEDICAL MARIJUANA USE IN THE STATE OF FLORIDA Highlights from
SEPTEMBER 15 2023 Report
BY THE NUMBERS Qualified Patients: (Active ID Card):
SEPT 15 2023- 845,249 SEPT 8 2023- 844,148 SEPT 1 2023 - 842,512
AUG 25 2023- 841,580 AUG 18 2023- 840,041 Patients Last Week: 1,101
Qualified Ordering Physicians: 2,649
New Doctors Last Week: 9 Reporting Period: SEPT 8 TO SEPT 13 2023 Amount of Medical Marijuana Dispensed - (mgs THC) 318,365,729
Amount of Low-THC Cannabis Dispensed - (mgs CBD) 2,782,491
Amount of Marijuana in a From for Smoking (oz) 99,371.736 Approved Dispensing Locations: 590 ADD LAST WEEK - 1 TRULIEVE - PACE |
UPCOMING MEETING AND CONFERENCES |
IT'S TIME TO SHOW THE HEALTHCARE COMMUNITY HOW YOU HELP THEIR PATIENTS
PARTICIPATE IN SFHHA ANNUAL GOLF TOURNAMENT |
ADVERTISEMENT OPPORTUNITIES
If your goal is to get your business in front of the right people in the cannabis industry or you want to be an integral part of this new and exciting business opportunity, then you need to join with Cannabis News Florida as we help to establish cannabis as a major part of the economy in Florida. Cannabis News Florida is an online publication focusing on both local and national news from leading authorities about the medical and business developments in the medical cannabis industry covering the entire state of Florida.
Join the Cannabis News Florida force online and in print. We offer several marketing options to fit all budgets:
· MMTC PROMOS LISTED IN EACH E-NEWSLETTER
• Directory Listing
• Banner Ads
• Ad Space in the Newspaper
• Feature Articles
• Weekly Newsletters
For further information or to make your ad reservation, please call:561-368-6950 / 954-605-4785 cell charles@cannabisnewsflorida.com
|
|
|